在卵巢癌的细胞减少手术中实施eras协议的治疗影响
Marianne Roy1, Tanguy Pace-Loscos2, Renaud Schiappa2
1Department of Breast and Gynecological Surgery, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06100 Nice, France.
概括
在上皮卵巢癌 (EOC) 手术中,手术后增强恢复 (ERAS) 协议可以改善恢复,减少并发症,并显示出更快地恢复瘤治疗的趋势. 遵守ERAS协议可以优化患者的治疗结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 基于证据的医学基于证据的医学.
背景情况:
- 手术后增强恢复 (ERAS) 协议在妇科瘤学中越来越多地使用.
- 这项研究评估了ERAS对皮卵巢癌 (EOC) 患者的生存的影响,这些患者接受了细胞减小手术.
研究的目的:
- 评估ERAS协议遵守对患上上皮质卵巢癌的患者的生存结果的影响.
- 为了比较ERAS和传统住院组之间的康复指标和并发症.
主要方法:
- 在两个中心进行了回顾性队列研究 (2011-2023年).
- 包括患有 FIGO 阶段 IC-IV EOC 的患者,接受了腹腔瘤细胞缩小术.
- 将患者分为ERAS遵守或常规住院 (CH) 组.
主要成果:
- 埃拉斯组的手术时间更短,住院时间更短 (8.5 vs 10.4 天).
- 遵守ERAS显著降低了延迟的术后并发症 (7.0%与24.9%相比).
- 复发率和60个月死亡率是可比的;在ERAS组中观察到更短时间恢复预期的瘤治疗 (RIOT) 的趋势.
结论:
- 在EOC手术中,ERAS协议的实施提高了术后恢复.
- 通过改善康复和减少并发症,ERAS显示出优化瘤管理的潜力.
- 减少RIOT的有希望趋势表明,ERAS可能有助于及时恢复癌症治疗.
相关概念视频
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


